Profile
Audrey Duval Derveloy is Executive Vice President & Head-Corporate Affairs at Sanofi since 2024.
Formerly, Dr. Derveloy was Head-Ophthalmology at Novartis Ireland Ltd. from 2013 to 2022 and President at Sanofi-Aventis France SA in 2022.
Dr. Derveloy completed undergraduate and doctorate degrees at Faculté de Médecine Paris.
Audrey Duval Derveloy active positions
| Companies | Position | Start |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 30/06/2024 |
Former positions of Audrey Duval Derveloy
| Companies | Position | End |
|---|---|---|
Novartis Ireland Ltd.
Novartis Ireland Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and consumer healthcare products for neuroscience, cardiovascular, immunology, oncology and cell | Corporate Officer/Principal | 31/07/2022 |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | President | - |
Education of Audrey Duval Derveloy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis Ireland Ltd.
Novartis Ireland Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical and consumer healthcare products for neuroscience, cardiovascular, immunology, oncology and cell | Health Technology |
Sanofi-Aventis France SA
Sanofi-Aventis France SA Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Faculté de Médecine Paris
Faculté de Médecine Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Audrey Duval Derveloy
















